课题基金 / 基金详情

SYNTHESIS AND FUNCTION OF A TRANSFORMATION-DEPENDENT SECRETED LYSOSOMAL PROTEASE

SYNTHESIS AND FUNCTION OF A TRANSFORMATION-DEPENDENT SECRETED LYSOSOMAL PROTEASE
转化依赖性分泌型溶酶体蛋白酶的合成和功能
批准号:
5200962
负责人:
M M GOTTESMAN
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

M M GOTTESMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Procathepsin L is the precursor to the lysosomal cysteine protease cathepsin L. It is secreted in large amounts by malignantly transformed mouse cells, and by cells treated with tumor promoters or growth factors. The function of procathepsin L in malignancy is not known, but involvement in tumor invasion and metastasis and in suppression of the immune response to tumors has been suggested. In normal tissues, procathepsin L is secreted by the liver, osteoclasts, and Sertoli cells, indicating possible involvement in bone resorption and sperm maturation. To study the biological function of procathepsin L, we are attempting to inactivate this gene by insertional mutagenesis into embryonic stem (ES) cells with the goal of establishing transgenic mice lacking cathepsin L function. We have cloned cathepsin L DNA isogenic with ES cell DNA into two targeting vectors (pPNT(s) and pSSC9) which carry different promoters and different numbers of Herpes Simplex Virus (HSV) thymidine kinase (tk) genes. The pSSC9 vector was constructed to allow for several unique restriction sites during cloning and to enhance the positive-negative selection strategy by incorporating two HSV-tk genes. The pPNT based vector which has been used successfully by other labs has been modified to allow for easier linearization. Attempts to inactivate cathepsin L in ES cells are in progress.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GENETIC ANALYSIS OF THE MULTIPLE DRUG RESISTANCE PHENOTYPE IN TUMOR CELLS
CONTROL OF SYNTHESIS OF A TRANSFORMATION-DEPENDENT SECRETED GLYCOPROTEIN
SYNTHESIS AND FUNCTION OF A TRANSFORMATION-DEPENDENT SECRETED LYSOSOMAL PROTEASE
SYNTHESIS AND FUNCTION OF A TRANSFORMATION-DEPENDENT SECRETED LYSOSOMAL PROTEASE
海外基金